These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31724305)

  • 1. Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration.
    Fetah KL; DiPardo BJ; Kongadzem EM; Tomlinson JS; Elzagheid A; Elmusrati M; Khademhosseini A; Ashammakhi N
    Small; 2019 Dec; 15(50):e1901985. PubMed ID: 31724305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances of Organ-on-a-Chip in Cancer Modeling Research.
    Liu X; Su Q; Zhang X; Yang W; Ning J; Jia K; Xin J; Li H; Yu L; Liao Y; Zhang D
    Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment.
    Tsai HF; Trubelja A; Shen AQ; Bao G
    J R Soc Interface; 2017 Jun; 14(131):. PubMed ID: 28637915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches.
    Sleeboom JJF; Eslami Amirabadi H; Nair P; Sahlgren CM; den Toonder JMJ
    Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29555848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging advances in immunopathology and artificial intelligence to analyze in vitro tumor models in composition and space.
    Leong TKM; Lo WS; Lee WEZ; Tan B; Lee XZ; Lee LWJN; Lee JJ; Suresh N; Loo LH; Szu E; Yeong J
    Adv Drug Deliv Rev; 2021 Oct; 177():113959. PubMed ID: 34481035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic systems for modeling digestive cancer: a review of recent progress.
    Razavi Z; Soltani M; Pazoki-Toroudi H; Dabagh M
    Biomed Phys Eng Express; 2024 Aug; 10(5):. PubMed ID: 39142294
    [No Abstract]   [Full Text] [Related]  

  • 7. Applications of Microfluidics and Organ-on-a-Chip in Cancer Research.
    Regmi S; Poudel C; Adhikari R; Luo KQ
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in 3D Vascularized Tumor-on-a-Chip Technology.
    Jung S; Jo H; Hyung S; Jeon NL
    Adv Exp Med Biol; 2022; 1379():231-256. PubMed ID: 35760994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-chip recapitulation of the tumor microenvironment: A decade of progress.
    Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
    Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening.
    Brooks A; Zhang Y; Chen J; Zhao CX
    Adv Healthc Mater; 2024 Aug; 13(21):e2302436. PubMed ID: 38224141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
    Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
    Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterials for Mimicking and Modelling Tumor Microenvironment.
    Das R; Fernandez JG
    Adv Exp Med Biol; 2022; 1379():139-170. PubMed ID: 35760991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-on-chip models for metastasis: importance of the tumor microenvironment.
    Jouybar M; de Winde CM; Wolf K; Friedl P; Mebius RE; den Toonder JMJ
    Trends Biotechnol; 2024 Apr; 42(4):431-448. PubMed ID: 37914546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
    Ferreira LP; Gaspar VM; Mano JF
    Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-on-a-chip meets artificial intelligence in drug evaluation.
    Deng S; Li C; Cao J; Cui Z; Du J; Fu Z; Yang H; Chen P
    Theranostics; 2023; 13(13):4526-4558. PubMed ID: 37649608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment.
    Portillo-Lara R; Annabi N
    Lab Chip; 2016 Oct; 16(21):4063-4081. PubMed ID: 27605305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast tumor-on-chip models: From disease modeling to personalized drug screening.
    Subia B; Dahiya UR; Mishra S; Ayache J; Casquillas GV; Caballero D; Reis RL; Kundu SC
    J Control Release; 2021 Mar; 331():103-120. PubMed ID: 33417986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Artificial Intelligence to In Vitro Tumor Modeling and Characterization of the Tumor Microenvironment.
    Lee RY; Wu Y; Goh D; Tan V; Ng CW; Lim JCT; Lau MC; Yeong JPS
    Adv Healthc Mater; 2023 Jun; 12(14):e2202457. PubMed ID: 37060240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic 3D models of cancer.
    Sung KE; Beebe DJ
    Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.